$7 Million in Annualized Revenues, in Excess of 15% Adjusted EBITDA Margin and Increases Protech’s Active Patient Count by More Than 10,000 5,000 Patients to Immediately Enter Protech’s Subscription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results